3 Stocks To Watch: Anthera Pharmaceuticals Inc(ANTH), KAR Auction Services Inc(KAR) and Cavium Inc(CAVM)

Posted by admin February 19, 2015 0 Comment 840 views

New York, NY – GDP INSIDER  –  02/19/2015.

This article discusses three companies: Anthera Pharmaceuticals Inc(NASDAQ:ANTH), KAR Auction Services Inc(NYSE:KAR) and Cavium Inc(NASDAQ:CAVM)

Anthera Pharmaceuticals Inc(NASDAQ:ANTH) was a top performer on Wednesday as it surged in value by over 18%.  Last week, the stock regained its position on the NASDAQ after meeting certain requirements making the shares more liquid.  In addition, the company completed the Phase 3 trial of a treatment for lupus.  The stock is up by 157% over the last three months compared to an increase of just 2.3% in the S&P 500 over that period.  Both of these recent positive catalysts have led to an improved outlook for Anthera Pharmaceuticals Inc shares and increased the likelihood of successfully marketing its new treatment.

Should You Place Your Pennies In Anthera Pharmaceuticals Inc? Click Here To See Why Investors Should Look To Buy ANTH.  

KAR Auction Services Inc(NYSE:KAR) provides vehicle auction services in North America.  It operates the ADESA, IAA, and AFC auction brands.  The company announced its earnings on February 17 and beat analysts’ forecasts.  EPS were $0.11 ahead of analyst estimates, and it provided in-line guidance. The shares jumped in value by 3.7%, and the environment is ripe for it to continue to beat current expectations.  The stock is approaching its 52-week high of $37.51 and has a NTM P/E of 19.1x.  The improved outlook and solid fundamentals are attractive for investors.

Will KAR Auction Services Inc Maintain Its Recent Gains? Click Here To See Why KAR Is An Interesting Buy.

Cavium Inc(NASDAQ:CAVM) shares increased by 6.3% on Wednesday.  The semiconductor processor firm has delivered double-digit or higher sales growth for the past nine quarters.  Fundamentals in the intelligent and secure network market and outperformance by the company have led to the strong sales growth.  The shares are up over 65% in the past year, and there is more room for upside.  The RSI and MFI at 67.1 and 69.4 are both positive leaning and do not indicate the imminent threat of a pullback in the shares.  Its revenue profile should continue to drive sales outperformance.

Should Investors Look To Buy Cavium Inc? Click Here To Learn More In Our Free CAVM.   

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

Write Your Comment